1 |
Rêgo Tde S, Ash Lda S, Pessoa L, et al.The intake of yam (Dioscorea bulbifera Linn) attenuated the hyperglycemia and the bone fragility in female diabetic rats[J]. Nutr Hosp, 2014, 29(2): 370-375.
|
2 |
Ghosh S, More P, Derle A, et al.Diosgenin from Dioscorea bulbifera: novel hit for treatment of type II diabetes mellitus with inhibitory activity against alpha-amylase and alpha-glucosidase[J]. PLoS One, 2014, 9(9): e106039.
|
3 |
Murray RDH, Jorge ZD, Khan NH, et al.Diosbulbin D and 8-epidiosbulbin E acetate, norclerodane diterpenoids from Dioscorea bulbifera tubers[J]. Phytochemistry, 1984, 23(3): 623-625.
|
4 |
张利平,周慧萍.黄药子致死亡1例[J].医药导报,2009,28(8):1097.
|
5 |
施海优,王志雄.黄药子致肝损害2例[J].浙江中西医结合杂志,2005,15(3):63-64.
|
6 |
Wang JM, Sheng YC, Ji LL, et al.Ferulic acid prevents liver injury and increases the anti-tumor effect of diosbulbin B in vivo[J]. J Zhejiang Univ Sci B, 2014, 15(6): 540-547.
|
7 |
Niu C, Sheng Y, Yang R, et al.Scutellarin protects against the liver injury induced by diosbulbin B in mice and its mechanism[J]. J Ethnopharmacol, 2015, 164: 301-308.
|
8 |
赵艳,朴宏鹰,褚晓杰,等.黄药子与甘草配伍对大鼠肝脏CYP_3A_1、CYP_2E_1 mRNA表达的影响[J].中国中医药科技,2011,18(4):304-305.
|
9 |
王秋红,杨欣,王蒙,等.黄芩与黄柏协同保护黄药子致肝毒性的实验研究[J].中国中药杂志,2016,41(5):898-903.
|
10 |
王旭东,鞠少卿.新一代测序技术在肿瘤精准医学中的应用[J].中华临床实验室管理电子杂志,2015,3(3):139-145.
|
11 |
孟宪欣,肖华胜.新一代测序技术在罕见病致病基因研究中的应用[J].生命科学,2015,27(7):960-967.
|
12 |
王曦,汪小我,王立坤,等.新一代高通量RNA测序数据的处理与分析[J].生物化学与生物物理进展,2010,37(8):834-846.
|
13 |
Ekblom R, Galindo J. Applications of next generation sequencing in molecular ecology of non-model organisms[J]. Heredity(Edinb), 2011, 107(1): 1-15.
|
14 |
Deng X, Pan L, Miao J, et al.Digital gene expression analysis of reproductive toxicity of benzo[a]pyrene in male scallop chlamys farreri[J]. Ecotoxicol Environ Saf, 2014, 110: 190-196.
|
15 |
Hewitt SC, Li L, Grimm SA, et al.Research resource: whole-genome estrogen receptor alpha binding in mouse uterine tissue revealed by ChIP-seq[J]. Mol Endocrinol, 2012, 26(5): 887-898.
|
16 |
Chen XH, Ma L, Hu YX, et al.Transcriptome profiling and pathway analysis of hepatotoxicity induced by tris(2-ethylhexyl) trimellitate(TOTM) in mice[J]. Environ Toxicol Pharmacol, 2016, 41: 62-71.
|
17 |
Wang J, Liang Q, Ji L, et al.Gender-related difference in liver injury induced by Dioscorea bulbifera L. rhizome in mice[J]. Hum Exp Toxicol, 2011, 30(9): 1333-1341.
|
18 |
Wang JM, Ji LL, Branford-White CJ, et al.Antitumor activity of Dioscorea bulbifera L. rhizome in vivo[J]. Fitoterapia, 2012, 83(2): 388-394.
|
19 |
Mortazavi A, Williams BA, Mccue K, et al.Mapping and quantifying mammalian transcriptomes by RNA-Seq[J]. Nat Methods, 2008, 5(7): 621-628.
|
20 |
Kakuma T, Lee Y, Unger RH.Effects of leptin, troglitazone, and dietary fat on stearoyl CoA desaturase[J]. Biochem Biophys Res Commun, 2002, 297(5): 1259-1263.
|
21 |
Ijpenberg A, Jeannin E, Wahli W, et al.Polarity and specific sequence requirements of peroxisome proliferator-activated receptor(PPAR)/retinoid X receptor heterodimer binding to DNA.A functional analysis of the malic enzyme gene PPAR response element[J]. J Biol Chem, 1997, 272(32): 20108-20117.
|
22 |
Kersten S, Desvergne B, Wahli W. Roles of PPARs in health and disease[J]. Nature, 2000, 405(6785): 421-424.
|
23 |
Kawano Y, Cohen DE.Mechanisms of hepatic triglyceride accumulation in non-alcoholic fatty liver disease[J]. J Gastroenterol, 2013, 48(4): 434-441.
|
24 |
Pawlak M, Lefebvre P, Staels B. Molecular mechanism of PPARalpha action and its impact on lipid metabolism, inflammation and fibrosis in non-alcoholic fatty liver disease[J]. J Hepatol, 2015, 62(3): 720-733.
|
25 |
Chen C, Wang DW.Cytochrome P450-CYP2 Family-Epoxygenase Role in Inflammation and Cancer[J]. Adv Pharmacol, 2015, 74: 193-221.
|
26 |
Mcdonnell AM, Dang CH.Basic review of the cytochrome p450 system[J]. J Adv Pract Oncol, 2013, 4(4): 263-268.
|
27 |
Samer CF, Lorenzini KI, Rollason V, et al.Applications of CYP450 testing in the clinical setting[J]. Mol Diagn Ther, 2013, 17(3): 165-184.
|
28 |
华碧春,黄智锋,刘娇,等.黄药子与甘草配伍对大鼠肝脏CYP450基因表达的影响[J].福建中医药大学学报,2014,24(1):19-21.
|
29 |
Lin D, Li C, Peng Y, et al.Cytochrome p450-mediated metabolic activation of diosbulbin B[J]. Drug Metab Dispos, 2014, 42(10): 1727-1736.
|